ArticleToxicology reports2025
Toxicological impact of Thiamethoxam on adult male rats: Histopathological, biochemical, and oxidative DNA damage assessment.
Article in Toxicology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Environmentally relevant concentrations of thiamethoxam cause cytotoxic and genotoxic damage in bullfrog (Lithobates catesbeianus) tadpoles.Ecotoxicology (London, England) · 2026Article
- Field-deployable supramolecular fluorescent sensing platform for selective dual-mode detection of thiamethoxam in complex environmental matrices.Mikrochimica acta · 2026Article
- Synergistic reproductive toxicity of lambda-cyhalothrin and thiamethoxam via oxidative stress and blood-testis barrier dysfunction in rats.Scientific reports · 2026Article
- Broad-Spectrum Hepatoprotection byFoods (Basel, Switzerland) · 2026Article
- Neonicotinoid-Induced Cytotoxicity: Insights into Cellular Mechanisms and Health Risks.Toxics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thiamethoxam (TMX), a widely used second-generation neonicotinoid insecticide, has raised concerns due to its toxic effects on non-target species, including mammals. Its prolonged use is associated with hepatotoxicity, nephrotoxicity, and reproductive damage. Objectives: This study evaluates the dose-dependent biochemical, histopathological, and genetic toxic effects of TMX in male albino rats, emphasizing its impact on the liver, kidney, and reproductive systems. Materials and methods: Forty male Wistar albino rats were assigned to control and three experimental groups treated with TMX at 26, 39, and 78 mg/kg/day over eight weeks. Key biochemical markers such as Alanine transaminase (ALT), Aspartate transaminase (AST), urea, creatinine and oxidative stress indicators (Catalase (CAT), Glutathione (GSH), Malondialdehyde (MDA), and reproductive parameters (testosterone, sperm count, and motility) were analyzed. Histopathological examination of the liver, kidney, and testes was performed, alongside evaluation of Deoxyribonucleic Acid (DNA) damage in testicular tissue. Results: TMX exposure caused significant dose-dependent increases in liver and kidney function markers and oxidative stress. Reproductive toxicity was evident, with reduced testosterone levels, impaired sperm parameters, and histopathological damage to testicular tissue. Notably, TMX induced oxidative DNA damage in testicular tissue, as indicated by increased levels of 8-hydroxy-2'-deoxyguanosine. Conclusions: This study highlights TMX's systemic toxicity in a dose-dependent manner, with oxidative stress and DNA damage as key mechanisms. The findings underscore the need for stricter regulatory measures and further exploration of protective strategies to mitigate TMX-induced toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.